What is duplimab and crisaborole?

Duplimab indicated for 6 years and older, human monoclonal Ab, tx of moderate to severe AD not controlled by topical therapies or contraindicated tx FDA approved. Crisaborole Phosphodiesterase inhibitor ointment tx mild-moderate AD children > 3 months of age.